Non-lethal bone marrow necrosis under first-line arsenic trioxide therapy in acute promyelocytic leukaemia

MeSH terms

• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Arsenic Trioxide
• Arsenicals / adverse effects*
• Arsenicals / therapeutic use
• Bone Marrow / drug effects
• Bone Marrow / pathology*
• Humans
• Leukemia, Promyelocytic, Acute / complications
• Leukemia, Promyelocytic, Acute / drug therapy*
• Male
• Middle Aged
• Necrosis / chemically induced
• Necrosis / pathology
• Oxides / adverse effects*
• Oxides / therapeutic use
• Treatment Outcome